Oxford

London: The Oxford-AstraZeneca COVID-19 vaccine is 67 per cent effective in reducing the spread of the virus after a single shot, a study published in the Lancet said. A two-dose regimen…

Bhubaneswar: While some COVID-19 vaccines such as Oxford-AstraZeneca, Pfizer and Moderna have been launched for emergency use in parts of the world, here are some other vaccines in…

New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the…

Mumbai: The Oxford-AstraZeneca vaccine being made at the Serum Institute in Pune will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna vaccines", Pascal…

Bhubaneswar: The year 2020 saw the Governor, Odisha government and ministers falling prey to fake news on social media. Two MPs also drew brickbats for their wrong tweets. Condolences too…

Mumbai: The COVID-19 vaccine, co-developed by the University of Oxford and drug manufacturer AstraZeneca, is likely to get emergency use approval first in India, a report has claimed.…

New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with AstraZeneca to…

Pune: Serum Institute of India CEO Adar Poonawalla is expecting approval for COVID-19 vaccine by end of December, while the vaccination drive in the country could start by next month.…

New Delhi: India will be deploying its vast election machinery to administer 60 crore doses in the next 6 to 8 months using standard cold chain systems. The reason for using conventional…

Chennai: A Chennai volunteer who has sued Serum Institute of India (SII) for adverse reactions of the Oxford vaccine, is facing difficulty in doing simple tasks such as writing, and has lost…